CFRA analysts increased the price target on Lonza Group (LONN:SW) (OTC: LZAGY) to CHF660 from the previous CHF610, while maintaining a "Buy" rating on the stock. The revised price target reflects an ...
Moderna is working with the Department of Health and Human Services to develop a vaccine to combat bird flu. Human to human transmission has not yet been reported.
R.F.K. Jr. and others have blamed the ingredient for allergies and other illnesses. Scientists say it actually bolsters the ...
The New York Times reports that the tentative $7.4 billion agreement with 15 states would also require those states to set aside as much as $800 million in what amounts to a legal defense fund for the ...
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
MRNA Total Operating Expenses (TTM) data by YCharts Moderna's operations burned through $2.7 billion during the 12 months that ended last September, but the company is finally getting a handle on ...
But three norovirus vaccines are in the works, with the furthest along from Moderna, which uses the same mRNA technology as the Covid-19 vaccine. Still, the pharma giant faces a major hurdle ...
Annual infections of the virus cost the global economy around $60 billion. But three norovirus vaccines are in the works, ...
Shares of Moderna Inc. fell sharply on Monday after the biotech firm projected a steep decline in 2025 revenues, falling below Wall Street expectations. The company, known for its COVID-19 vaccine ...
Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says. Though most people recover from the ...